| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.18▲ | 1.18▲ | 1.18▲ | 1.14▲ | 1.12▲ |
| MA10 | 1.19▲ | 1.18▲ | 1.18▲ | 1.11▲ | 1.16▲ |
| MA20 | 1.18▲ | 1.17▲ | 1.15▲ | 1.10▲ | 1.17▲ |
| MA50 | 1.15▲ | 1.11▲ | 1.10▲ | 1.17▲ | 1.19▲ |
| MA100 | 1.11▲ | 1.12▲ | 1.12▲ | 1.17▲ | 2.28▼ |
| MA200 | 1.15▲ | 1.18▲ | 1.19▼ | 1.19▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.001▼ | 0.001▲ | 0.017▲ | 0.000▼ |
| RSI | 55.072▲ | 57.935▲ | 59.742▲ | 60.095▲ | 50.238▲ |
| STOCH | 65.000 | 69.231 | 68.205 | 75.212 | 23.923 |
| WILL %R | -20.000▲ | -15.385▲ | -15.385▲ | -10.000▲ | -56.098 |
| CCI | 34.440 | 58.749 | 70.227 | 169.362▲ | -49.799 |
|
Wednesday, November 12, 2025 01:00 PM
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today reported ...
|
|
Tuesday, November 11, 2025 08:01 PM
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today reported ...
|
|
Monday, November 10, 2025 04:00 AM
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics through its boron chemistry platform, today announced a collaboration agreement with the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/12/25 | 1.12 | 1.20 | 1.12 | 1.19 | 38,861 |
| 10/12/25 | 1.14 | 1.21 | 1.1363 | 1.18 | 63,954 |
| 09/12/25 | 1.09 | 1.17 | 1.09 | 1.15 | 72,111 |
| 08/12/25 | 1.165 | 1.165 | 1.05 | 1.10 | 79,817 |
| 05/12/25 | 1.07 | 1.10 | 1.03 | 1.10 | 153,068 |
| 04/12/25 | 1.08 | 1.11 | 1.045 | 1.065 | 70,502 |
| 03/12/25 | 1.06 | 1.11 | 1.05 | 1.07 | 43,932 |
| 02/12/25 | 1.07 | 1.09 | 1.04 | 1.06 | 22,723 |
| 01/12/25 | 1.05 | 1.12 | 1.045 | 1.05 | 93,106 |
| 28/11/25 | 1.06 | 1.11 | 1.01 | 1.09 | 149,202 |
|
|
||||
|
|
||||
|
|